In this episode, we express skepticism regarding the impacts of Anthropic's IPO on the AI landscape. Additionally, we highlight the promising partnership with Novo Nordisk and its implications for healthcare.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, we express skepticism regarding the impacts of Anthropic's IPO on the AI landscape. Additionally, we highlight the promising partnership with Novo Nordisk and its implications for healthcare. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Skepticism Around Anthropic's IPO

<p>Welcome to AI Data, the show that covers the most important news in artificial intelligence. From fresh breakthroughs to the companies leading the way, each episode helps you stay informed on the fast moving world of AI.</p>

Technology

Welcome to AI Data, the show that covers the most important news in artificial intelligence. From fresh breakthroughs to the companies leading the way, each episode helps you stay informed on the fast moving world of AI.

Share Skepticism Around Anthropic's IPO

Sign up to save your podcasts

Skepticism Around Anthropic's IPO

Skepticism Around Anthropic's IPO